Erytech Pharma | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,112.50
36,988.40
45,634.00
37,646.00
185,525.00
134,371
Total Accounts Receivable
1,687.00
2,122.80
5,909.00
4,403.00
4,540.00
9,679
Inventories
138.20
198.40
166.00
145.00
176.00
1,396
Other Current Assets
101.10
216.80
220.00
339.00
1,327.00
4,461
Total Current Assets
17,038.80
39,526.40
51,929.00
42,533.00
191,568.00
149,907
Net Property, Plant & Equipment
812.90
967.50
918.00
2,245.00
3,406.00
15,274
Total Investments and Advances
-
-
-
-
168.00
-
Long-Term Note Receivable
0.40
-
-
-
-
-
Intangible Assets
14.30
31.00
61.00
57.00
53.00
1,613
Other Assets
82.50
81.80
96.00
132.00
66.00
1,046
Total Assets
17,949.00
40,606.60
53,004.00
44,967.00
195,261.00
167,840
ST Debt & Current Portion LT Debt
281.30
333.50
557.00
50.00
824.00
Accounts Payable
1,421.40
2,084.50
3,672.00
4,832.00
4,966.00
Other Current Liabilities
1,811.90
1,839.70
1,392.00
1,465.00
5,816.00
Total Current Liabilities
3,514.60
4,257.70
5,621.00
6,347.00
11,606.00
Long-Term Debt
730.50
436.00
151.00
2,816.00
2,019.00
Provision for Risks & Charges
117.10
88.60
100.00
163.00
214.00
Deferred Taxes
-
-
-
3.00
3.00
Total Liabilities
4,362.30
4,782.30
5,872.00
9,329.00
13,842.00
Common Equity (Total)
13,586.60
35,824.30
47,132.00
35,638.00
181,419.00
Total Shareholders' Equity
13,586.60
35,824.30
47,132.00
35,638.00
181,419.00
Total Equity
13,586.60
35,824.30
47,132.00
35,638.00
181,419.00
Liabilities & Shareholders' Equity
17,949.00
40,606.60
53,004.00
44,967.00
195,261.00
About Erytech Pharma
View Profile
